Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-B )
NCT06492265 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2024-08-12
Summary
To compare the door-to-puncture time of patients with hyperacute ischemic stroke (between 4.5-6 hours after the onset of symptoms) treated in a standard stroke unit adherent to guidelines versus treated in Emergency Stroke Unit (a new stroke unit based on low-field magnetic resonance imaging).
Conditions
- Ischemic Stroke, Acute
Interventions
- COMBINATION_PRODUCT
-
Emergency Stroke Unit based on 0.23-T MRI
The participants with hyperacute ischemic stroke (between 4.5-6 hours after onset of symptoms) who are eligible to receive reperfusion therapy will be managed by Emergency Stroke Unit process based on low-field magnetic resonance imaging.
- COMBINATION_PRODUCT
-
Standard stroke unit adherent to guidelines
The participants with hyperacute ischemic stroke (between 4.5-6 hours after onset of symptoms) who are eligible to receive reperfusion therapy will be managed by standard stroke unit process adherent to guidelines.
Sponsors & Collaborators
-
Yongjun Wang
lead OTHER
Principal Investigators
-
Yongjun Wang, MD, PhD · Beijing Tiantan Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-04
- Primary Completion
- 2025-02-01
- Completion
- 2025-04-01
Countries
- China
Study Locations
More Related Trials
-
Endovascular Therapy for Acute Ischemic Stroke Trial
NCT02350283 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Finding Study of MCI-186 in Acute Ischemic Stroke
NCT03346538 ·Status: TERMINATED ·Phase: PHASE2
-
Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism
NCT03090113 ·Status: COMPLETED ·Phase: PHASE4
-
Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management
NCT07279259 ·Status: RECRUITING ·Phase: PHASE2
-
Study on the Role of Human Serum Albumin in Large Acute Ischemic Stroke of Anterior Circulation After Thrombectomy
NCT06629116 ·Status: RECRUITING ·Phase: NA
-
Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke With Occlusion of the M2 Segment of Middle Cerebral Artery
NCT07347665 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Intra-arterial Bone-marrow Mononuclear Cells Infusion for Acute Ischemic Stroke
NCT02178657 ·Status: COMPLETED ·Phase: PHASE2
-
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2
NCT07263308 ·Status: RECRUITING ·Phase: PHASE3
-
Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke
NCT04950790 ·Status: UNKNOWN ·Phase: PHASE4
-
The Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Due to Large Core Infarction
NCT07333950 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan RCT
NCT02419781 ·Status: TERMINATED ·Phase: NA
-
Phase I Clinical Safety Study About Human Umbilical Cord Blood Monocyte in the Acute Ischemic Stroke
NCT02433509 ·Status: COMPLETED ·Phase: PHASE1
-
Normobaric Hyperoxia Combined With Reperfusion for Acute Ischemic Stroke
NCT03620370 ·Status: COMPLETED ·Phase: NA
-
Endovascular Thrombectomy With and Without Intravenous Thrombolysis in Extended Time Window
NCT05634382 ·Status: UNKNOWN ·Phase: PHASE3
-
The Androtriol Injection for the Treatment of Acute Ischemic Stroke
NCT06679322 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Acute Basilar Artery Occlusion: Endovascular Interventions vs Standard Medical Treatment
NCT02441556 ·Status: COMPLETED ·Phase: NA
-
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
NCT02448641 ·Status: COMPLETED ·Phase: PHASE2
-
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
NCT06226805 ·Status: RECRUITING ·Phase: PHASE2
-
"Mobile Stroke Unit"-Concept for Delivery of Specialized Acute Stroke Care to Patients in Remote Areas
NCT02465346 ·Status: COMPLETED ·Phase: NA
-
Registration of Intravenous Thrombolysis for Acute Ischemic Stroke in Southwestern China(IVTIS)
NCT06131385 ·Status: RECRUITING
-
Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT)
NCT07119021 ·Status: RECRUITING ·Phase: PHASE4
-
Safety and Pharmacokinetic Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke
NCT00870844 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke
NCT02430350 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke
NCT00283088 ·Status: COMPLETED ·Phase: PHASE1